Radioembolization News and Research

RSS
A type of radiation therapy used to treat liver cancer that is advanced or has come back. Tiny beads that hold the radioisotope yttrium Y 90 are injected into the hepatic artery (the main blood vessel that carries blood to the liver).
Targeted radiation provides treatment option for children with hard-to-treat liver cancer

Targeted radiation provides treatment option for children with hard-to-treat liver cancer

Bayshore Medical Center now offers Y-90 radioembolization to treat liver tumors without surgery

Bayshore Medical Center now offers Y-90 radioembolization to treat liver tumors without surgery

Study confirms no survival benefit of adding SIRT to standard treatment for liver cancer

Study confirms no survival benefit of adding SIRT to standard treatment for liver cancer

Oxygen-filled microbubbles make breast tumors more sensitive to radiation therapy

Oxygen-filled microbubbles make breast tumors more sensitive to radiation therapy

Study reveals promising results for primary liver cancer patients treated with SIR-Spheres Y-90 resin microspheres

Study reveals promising results for primary liver cancer patients treated with SIR-Spheres Y-90 resin microspheres

MGH-developed CTC-iChip with digital PCR assay improves detection of early-stage liver cancer

MGH-developed CTC-iChip with digital PCR assay improves detection of early-stage liver cancer

Innovative liver cancer treatment gets EU approval

Innovative liver cancer treatment gets EU approval

SARAH study completes patient enrolment to evaluate treatment for primary liver cancer

SARAH study completes patient enrolment to evaluate treatment for primary liver cancer

UMC Utrecht and Quirem Medical team up to develop holmium microspheres for liver cancer

UMC Utrecht and Quirem Medical team up to develop holmium microspheres for liver cancer

Symposium focused on Surefire Medical's COSY clinical trial to be held at ECIO meeting

Symposium focused on Surefire Medical's COSY clinical trial to be held at ECIO meeting

Surefire Medical's new line of Surefire Guiding Catheters receive FDA clearance and CE Mark

Surefire Medical's new line of Surefire Guiding Catheters receive FDA clearance and CE Mark

Surefire Medical enrolls patients in COSY clinical trial to investigate benefits of SIRT in liver metastasis

Surefire Medical enrolls patients in COSY clinical trial to investigate benefits of SIRT in liver metastasis

European regulators approve Surefire Infusion System for chemo- and radioembolization procedures

European regulators approve Surefire Infusion System for chemo- and radioembolization procedures

CCI, NextBio partner to adopt genomics in the clinic

CCI, NextBio partner to adopt genomics in the clinic

Nordion announces additional TheraSphere Phase III trial for HCC

Nordion announces additional TheraSphere Phase III trial for HCC

Enrollment opens in sorafenib vs. radioembolization in advanced hepatocellular carcinoma trial

Enrollment opens in sorafenib vs. radioembolization in advanced hepatocellular carcinoma trial

Advances in yttrium-90 radioembolization for liver cancer

Advances in yttrium-90 radioembolization for liver cancer

Survival for patients with HCC increases with radioembolization

Survival for patients with HCC increases with radioembolization

MRG: Radioembolization is expected to grow from $50M in sales in 2011 to $128M in 2015

MRG: Radioembolization is expected to grow from $50M in sales in 2011 to $128M in 2015

Study: Y-90 radioembolization is a safe treatment for patients with liver cancer

Study: Y-90 radioembolization is a safe treatment for patients with liver cancer